Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effekten av hundeadopsjon og trening hos veteraner med posttraumatiske stressymptomer og/eller andre psykiske helsetilstander (VCRM)

6. november 2026 oppdatert av: Beth Pratt, Florida Atlantic University

Vurdering av biopsykososiale indikatorer knyttet til respons på hundebasert intervensjonsbehandling hos veteraner med posttraumatiske stressymptomer og/eller andre psykiske helseproblemer

The goal of this single-arm study is to learn if a dog adoption and training program can treat, prevent in [describe participant population/primary condition; could include any of the following: sex/gender, age groups, healthy volunteers]. The main questions it aims to answer are:

  • Does the dog adoption and training program decrease posttraumatic stress symptoms in veterans with self-reported posttraumatic stress symptoms?
  • Does the dog adoption and training program decrease stress and improve psychosocial health in veterans with self-reported posttraumatic stress symptoms?
  • Does the dog adoption and training program decrease inflammation, increase oxytocin, and change the structure and resting-state function of specific brain regions in veterans with self-reported posttraumatic stress symptoms?

Participants will:

  • Attend eight one-hour professional dog training sessions within a 10-week period.
  • Visit the clinical research unit four times during the study for data collection.

Studieoversikt

Status

Rekruttering

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Antatt)

120

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Florida
      • Boca Raton, Florida, Forente stater, 33431
        • Rekruttering
        • Florida Atlantic University

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Military veteran with self-reported posttraumatic stress symptoms and/or other mental health conditions
  • Over 18 years of age
  • Applied and approved to adopt a shelter dog for training through the Humane Society of Broward County in Fort Lauderdale, Florida
  • English speaker (written and spoken)
  • Home internet access via tablet, computer or smartphone.

Exclusion Criteria:

  • Fear of dogs
  • Allergies to pet dander
  • Uncorrected hearing or visual impairment.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Study Intervention

Within-subjects design

Eight, one-hour professional dog training sessions over 8-10 weeks

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in self-reported posttraumatic stress disorder (PTSD) symptoms from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention

Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) is a 20-item self-report measure of PTSD symptoms with scores ranging from 0 to 80.

From enrollment to 4 weeks post-intervention

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in depression symptom severity from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention

Patient Health Questionnaire-9 (PHQ-9) is a 9-item self-report measure of depressive symptoms with scores ranging from 0 to 27.

From enrollment to 4 weeks post-intervention
Change in anxiety symptom severity from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention

Generalized Anxiety Disorder-7 (GAD-7) is a is a 7-item self-report measure of anxiety symptoms with scores ranging from 0 to 21.

From enrollment to 4 weeks post-intervention
Change in perceived stress severity from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention

Perceived Stress Scale-10 (PSS-10) is a 10-item self-report measure of perceived stress symptoms with scores ranging from 0 to 40.

From enrollment to 4 weeks post-intervention
Change in sleep disturbance from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention

Patient-Reported Outcomes Measurement Information System Sleep 8b (PROMIS Sleep 8b) is an 8-item self-report measure of sleep quality over the past 7 days with raw scores ranging from 8 to 40 and standardized T scores ranging from 28.9 to 76.5.

From enrollment to 4 weeks post-intervention
Change in loneliness from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention

Revised UCLA Loneliness Scale is a 20-item self-report measure of loneliness with scores ranging from 20 to 80.

From enrollment to 4 weeks post-intervention
Change in alcohol use from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention

Alcohol Use Disorder Identification Test (AUDIT) is a 10-item self-report measure of alcohol use with scores ranging from 0 to 40.

From enrollment to 4 weeks post-intervention
Change in cannabis use from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention

Cannabis Use Disorder Identification Test (CUDIT) is an 8-item self-report measure of cannabis use with scores ranging from 0 to 32.

From enrollment to 4 weeks post-intervention
Change in salivary oxytocin levels from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention

Oxytocin is a neurotransmitter that plays a role in determining social behavior. Salivary oxytocin levels range from 6.4-1000 pg/mL.

From enrollment to 4 weeks post-intervention
Change in Interleukin-1 beta (IL-1β) from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention

IL-1β is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. IL-1β is measured via capillary blood obtained via fingerstick.

From enrollment to 4 weeks post-intervention
Change in Interleukin-6 (IL-6) from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention

IL-6 is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. IL-6 is measured via capillary blood obtained via fingerstick.

From enrollment to 4 weeks post-intervention
Change in tumor necrosis factor-alpha (TNF-alpha) from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention

TNF-alpha is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. TNF-alpha is measured via capillary blood obtained via fingerstick.

From enrollment to 4 weeks post-intervention

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in alcohol demand for participants who answer "yes" to alcohol consumption in the AUDIT measure from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention

Alcohol Purchase Task is a tool to measure alcohol demand by asking individuals how many drinks they would consume at prices ranging from free to high, using behavioral economic indices for scoring.

From enrollment to 4 weeks post-intervention
Change in cannabis demand for participants who answer "yes" to cannabis use from baseline to 4 weeks post-intervention
Tidsramme: From enrollment to 4 weeks post-intervention

Cannabis Purchase Task is a tool to measure cannabis demand by assessing how much an individual purchases at increasing prices.

From enrollment to 4 weeks post-intervention
Change in Magnetic Resonance Imaging (MRI) biomarkers from baseline to 4 weeks post-intervention
Tidsramme: Pre-intervention and 4 weeks post-intervention

Optional participation in an MRI to detect changes in the structure and resting-state function of specific brain regions (anterior cingulate, amygdala, hippocampus, and insula)

Pre-intervention and 4 weeks post-intervention

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Etterforskere

  • Hovedetterforsker: Beth A Pratt, PhD, Florida Atlantic University
  • Hovedetterforsker: Cheryl A Krause-Parello, PhD, Florida Atlantic University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

9. februar 2026

Primær fullføring (Antatt)

1. desember 2030

Studiet fullført (Antatt)

1. desember 2030

Datoer for studieregistrering

Først innsendt

14. april 2026

Først innsendt som oppfylte QC-kriteriene

14. april 2026

Først lagt ut (Faktiske)

21. april 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

12. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

6. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • IRB2310227

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .